Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Stefano Gemini"'
Autor:
Elton Dajti, Federico Ravaioli, Giovanni Marasco, Luigina Vanessa Alemanni, Luigi Colecchia, Alberto Ferrarese, Caterina Cusumano, Stefano Gemini, Amanda Vestito, Matteo Renzulli, Rita Golfieri, Davide Festi, Antonio Colecchia
Publikováno v:
The American journal of gastroenterology. 117(11)
A noninvasive diagnosis of clinically significant portal hypertension (CSPH) has important prognostic and therapeutic implications for patients with compensated advanced chronic liver disease. We aimed to validate and improve the available algorithms
Autor:
Nicola Passigato, Elton Dajti, Angelo Tonon, Stefano Gemini, Antonio Colecchia, Federico Ravaioli, Alberto Ferrarese, Caterina Cusumano, Giovanni Marasco
Publikováno v:
World Journal of Hepatology
Patients with cirrhosis show an increased susceptibility to infection due to disease-related immune-dysfunction. Bacterial infection therefore represents a common, often detrimental event in patients with advanced liver disease, since it can worsen p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1f411c70cceb752eedb288db077a5c17
https://hdl.handle.net/11380/1280928
https://hdl.handle.net/11380/1280928
Autor:
Elton Dajti, Federico Ravaioli, Giovanni Marasco, Vanessa Alemanni, Luigi Colecchia, Alberto Ferrarese, Caterina Cusumano, Stefano Gemini, Amanda Vestito, Matteo Renzulli, Rita Golfieri, Davide Festi, Antonio Colecchia
Publikováno v:
Digestive and Liver Disease. 54:S7
Autor:
Mario Scartozzi, Luca Faloppi, Gianluca Svegliati Baroni, Cristian Loretelli, Massimo Iavarone, Pierluigi Toniutto, Giammarco Fava, Samuele De Minicis, Alessandra Mandolesi, Maristella Bianconi, Riccardo Giampieri, Floriana Facchetti, Davide Bitetto, Sara Vavassori, Stefano Gemini, Massimo Colombo, Italo Bearzi, Antonio Benedetti, Stefano Cascinu, PISCAGLIA, FABIO, GRANITO, ALESSANDRO, MARINELLI, SARA, VENERANDI, LAURA, D'ERRICO, ANTONIETTA, BOLONDI, LUIGI
Although new treatment modalities changed the global approach to hepatocellular carcinoma (HCC), this disease still represents a medical challenge. Currently, the therapeutic stronghold is sorafenib, a tyrosine kinase inhibitor (TKI) directed against
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::02904513f4533ab6759d74253fa82917